Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-10-06

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' ketorolac tromethamine as a generic injectable NSAID for short-term management of acute pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)